Galway, Ireland-based Medtronic plc (MDT) is a global healthcare technology company that develops and manufactures medical devices, software, and AI-powered solutions to treat more than 70 medical conditions. With a market capitalization of approximately $105.4 billion, its products support cardiovascular, neuroscience, diabetes, surgical, and other therapies to improve patient outcomes worldwide.
MDT is set to report its Q1 earnings on Tuesday, September 1, 2026, before the market opens. Ahead of the release, analysts expect the company to report diluted EPS of $1.38, up 9.5% from $1.26 in the year-ago quarter. Likewise, MDT has surpassed Wall Street's EPS estimates in each of the past four quarters, which is impressive.